CTLA-4 on T cells throughout the induction phase of an anti-cancer immune reaction obstructs T cell activation by inhibiting the formation of interaction between CD80/CD86 and CD28 and conveying inhibitory signals, directly suppressing T cell activation [13, 14]. This evidence concerns the gene CTLA4 and cancer.